InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Primocin® | Microbiota-derived tryptophan catabolites mediate the chemopreventive effects... | 2023 | Nat Microbiol. | Han J.X. et al. | DOI: 10.1038/s41564-023-01363-5 |
Anti-mouse Dectin-1 (CLEC7A) antibody | The Alzheimer's disease risk factor INPP5D restricts neuroprotective microgli... | 2023 | Alzheimers Dement. | Samuels J.D. et al. | DOI: 10.1002/alz.13089 |
Plasmocin® - Mycoplasma Elimination Reagent | The potential effects of in vitro digestion on the physicochemical and biolog... | 2023 | Environ Pollut. | Vela L. et al. | DOI: 10.1016/j.envpol.2023.121656 |
IL-18 Reporter HEK 293 Cells | Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflamma... | 2023 | PLoS Pathog. | Johnson A.F. et al. | DOI: 10.1371/journal.ppat.1011321 |
Normocin® - Antimicrobial Reagent | Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflamma... | 2023 | PLoS Pathog. | Johnson A.F. et al. | DOI: 10.1371/journal.ppat.1011321 |
Caspase-1 and Caspase-4 inhibitor | Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflamma... | 2023 | PLoS Pathog. | Johnson A.F. et al. | DOI: 10.1371/journal.ppat.1011321 |
Recombinant human IL-18 | Constitutive secretion of pro-IL-18 allows keratinocytes to initiate inflamma... | 2023 | PLoS Pathog. | Johnson A.F. et al. | DOI: 10.1371/journal.ppat.1011321 |
MPLA Synthetic VacciGrade™ | Immune responses to citrullinated and homocitrullinated peptides in healthy d... | 2023 | Immunology | Choudhury R.H. et al. | DOI: 10.1111/imm.13645 |
ODN 1826 VacciGrade™ | Immune responses to citrullinated and homocitrullinated peptides in healthy d... | 2023 | Immunology | Choudhury R.H. et al. | DOI: 10.1111/imm.13645 |
Puromycin | An in vivo CRISPR screen identifies that SNRPC promotes triple-negative breas... | 2023 | Cancer Res. | Lu X.X. et al. | DOI: 10.1158/0008-5472.CAN-22-0536 |
LPS-EB (LPS from E. coli O111:B4) | XIAP deletion sensitizes mice to TNF-induced and RIP1-mediated death. | 2023 | Cell Death Dis. | Witt A. et al. | DOI: 10.1038/s41419-023-05793-1 |
Human TLR2 Reporter HEK293 Cells (NF-κB) | Pushing the boundaries of structural heterogeneity with the lipid A of marine... | 2023 | Chembiochem. | Cirella R. et al. | DOI: 10.1002/cbic.202300183 |
HEK-Blue™ Null2 Cells | Pushing the boundaries of structural heterogeneity with the lipid A of marine... | 2023 | Chembiochem. | Cirella R. et al. | DOI: 10.1002/cbic.202300183 |
HEK-Blue™ Selection | Pushing the boundaries of structural heterogeneity with the lipid A of marine... | 2023 | Chembiochem. | Cirella R. et al. | DOI: 10.1002/cbic.202300183 |
Pam3CSK4 | Pushing the boundaries of structural heterogeneity with the lipid A of marine... | 2023 | Chembiochem. | Cirella R. et al. | DOI: 10.1002/cbic.202300183 |
CL264 | TLR7 activation in M-CSF-dependent monocyte-derived human macrophages potenti... | 2023 | J Innate Immun. | Simón-Fuentes M. et al. | DOI: 10.1159/000530249 |
Blasticidin | Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppress... | 2023 | Neoplasia | Cui X. et al. | DOI: 10.1016/j.neo.2023.100900 |
Puromycin | Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppress... | 2023 | Neoplasia | Cui X. et al. | DOI: 10.1016/j.neo.2023.100900 |
OVA peptides | Synergistic effects of combined immunotherapy strategies in a model of multif... | 2023 | Cell Rep Med. | Ochoa M.C. et al. | DOI: 10.1016/j.xcrm.2023.101009 |
Human TLR2 and TLR1 Reporter HEK293 Cells (NF-κB) | Engineered Curli Nanofilaments as a Self‐Adjuvanted Antigen Delivery Platform. | 2023 | Adv Healthc Mater. | Lamontagne F. et al. | DOI: 10.1002/adhm.202300224 |